Results 51 to 60 of about 2,713 (225)
US State Policy Index for Population Health Analyses
Policy Points Changes in states’ policy contexts since the 1980s may help explain why mortality rates among working‐age adults have risen and become more unequal across geographic areas. Investigating this pressing issue requires a new, industry‐standard measure of those contexts.
JENNIFER KARAS MONTEZ +2 more
wiley +1 more source
Brand switching and toxic chemicals in cigarette smoke: A national study
US law requires disclosure of quantities of toxic chemicals (constituents) in cigarette smoke by brand and sub-brand. This information may drive smokers to switch to cigarettes with lower chemical quantities, under the misperception that doing so can reduce health risk.
Jennifer R. Mendel +8 more
openaire +4 more sources
Toxic Chemicals in Cigarette Mainstream Smoke - Hazard and Hoopla [PDF]
Abstract These are curious times. The Canadian government has passed legislation that requires cigarette manufacturers to routinely test and publish the amounts of 44 toxic substances in cigarette mainstream smoke (MSS). Following in the footsteps of their northern neighbor, various US legislators and regulators are considering ...
A Rodgman, CR Green
openaire +1 more source
AbstractElectronic cigarette (EC) has been suggested to be less harmful than cigarette smoking, but the research on the full extent of their harm reduction potential is still lacking. This study aimed to evaluate the influence of EC aerosol and cigarette smoke (CS) on cardiovascular, gastrointestinal, and renal functions in mice after prolonged ...
Aijing Xu +8 more
openaire +3 more sources
Abstract Background/Aims E‐cigarettes are frequently used by people who smoke. This study measured how the prevalence and patterns of smoking and vaping (‘dual use’) in England have changed as the vaping market has rapidly evolved. Design Representative monthly cross‐sectional survey, July 2016 to April 2024. Setting England.
Sarah E. Jackson +3 more
wiley +1 more source
International audienceIn animals, cigarette smoke may alter pharmacokinetics by altering activity and expression of ABC drug transporters. We previously demonstrated that cigarette smoke condensate (CSC) impairs activity and expression of several hepatic
Chamieh, Hala +4 more
core +1 more source
Abstract Background and aims Oral nicotine pouches (ONPs) contain varying proportions of freebase nicotine (FBN), with higher FBN expected to increase nicotine delivery across the oral mucosa. Because ONPs contain fewer toxicants than moist snuff and may serve as a reduced harm alternative for smokeless tobacco, we compared how the FBN in ONPs affects ...
Brittney Keller‐Hamilton +10 more
wiley +1 more source
Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2‐year follow up [PDF]
Background and aimsA broadly mandated reduction of the nicotine content (RNC) of cigarettes has been proposed in the United States to reduce the addictiveness of cigarettes, to prevent new smokers from becoming addicted and to facilitate quitting in ...
Jacob, Peyton +6 more
core +1 more source
Comparison of monoamine oxidase inhibition by cigarettes and modified risk tobacco products
The adverse effects of cigarette smoking are well documented, and the two main strategies for reducing smoking prevalence are prevention of smoking initiation and promotion of smoking cessation.
Marco van der Toorn +6 more
doaj +1 more source
Abstract Background and aims Tobacco‐free nicotine pouches (NPs) are oral nicotine products promoted by manufacturers and some researchers as tools that may reduce nicotine cravings and support smoking reduction or cessation. However, evidence regarding their actual clinical impact remains limited.
Javad Heshmati +6 more
wiley +1 more source

